magAssist was selected as one of the top 50 innovative companies in the 21st century by the world famous innovation list MIC50: Top 50 Innovative Companies

On December 15, the internationally renowned innovation list MIC50: Top 50 Innovative Companies of the 21st Century (FastCompany China's Best Innovative Companies 50) was released. magAssist was selected from a large number of companies as one of the Top 50 Innovative Companies of the 21st Century (Nationwide), and the list also included giants from various industries such as Anta, bilibili, Tencent, Mango TV, and DingTalk.


magAssist was selected as one of the top 50 innovative companies in the 21st century by the world famous innovation list MIC50: Top 50 Innovative Companies


Since 2008, FastCompany, one of the three largest business media in the United States, has launched the annual "World's Best 50 Innovative Companies" list, which has become a list of global reputation. The list was created by the team of FastCompany China.


The team selected the "Top 50 Best Innovative Companies in China" with a unique understanding of "innovation" and an international professional vision, based on years of data accumulation and special research, after a comprehensive consideration of international and domestic innovation and economic development.


magAssist has completed the development of its first-class III high-tech barrier active product, the extracorporeal magnetically levitated ventricular assist device, from scratch in three years. Its technology is built upon mechatronics, magnetic levitation and computational fluid dynamics. The product has now entered the clinic and successfully saved many patients. In just over four years, magAssist has become the company with the fastest R&D progress and the most complete product line in the field of extracorporeal life support in China.


Winning the Top 50 Innovative Companies is a meaningful recognition for magAssist. In the future, magAssist will continue to develop platform-based solutions for external life support systems that meet the needs of different populations, support requirements and clinical scenarios, and serve cardiovascular patients in China and worldwide.


E-mail     Share on Linkedin     Share on Facebook
Recommendation